About this Journal Submit a Manuscript Table of Contents
Advances in Hematology
Volume 2012 (2012), Article ID 535709, 6 pages
http://dx.doi.org/10.1155/2012/535709
Review Article

JAK2 Inhibition: Reviewing a New Therapeutical Option in Myeloproliferative Neoplasms

Department of Hematology, Erasmus University Medical Center, P.O. Box 2040, 3000 CA Rotterdam, The Netherlands

Received 12 September 2011; Revised 29 November 2011; Accepted 4 December 2011

Academic Editor: Mark R. Litzow

Copyright © 2012 Mar Bellido and Peter A. W. te Boekhorst. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Mar Bellido and Peter A. W. te Boekhorst, “JAK2 Inhibition: Reviewing a New Therapeutical Option in Myeloproliferative Neoplasms,” Advances in Hematology, vol. 2012, Article ID 535709, 6 pages, 2012. doi:10.1155/2012/535709